PI Industries shares plunged 7.48% to an intraday low of ₹2,889 during Wednesday's trading session, following the release of disappointing Q4 results for the quarter ended March 31, 2026. The stock has declined over 4.38% in a week and 4% in a month, with a 9.38% drop on a year-to-date basis and 22% decline over the past year. According to latest reports, weak technicals and declining institutional holding have added to investor concerns over the company's performance.
For the March quarter, PI Industries reported a 12% year-on-year decline in revenue to ₹1,565 crore, which was broadly in line with market expectations. The company's consolidated net profit dropped 39.4% YoY to ₹200 crore from ₹331 crore, marking the seventh time in the last nine quarters that the company has missed Street expectations. EBITDA fell 26% to ₹337 crore during the quarter, with EBITDA margin contracting to 21.5% from 25.5% a year ago, significantly below the company's earlier guidance of 25% to 27%. For the full financial year FY26, profit declined 20% to ₹1,320 crore versus ₹1,660 crore in the previous year, while annual revenue dropped 16% to ₹6,713 crore from ₹7,977 crore in FY25.
Despite the weak financial performance, the board recommended a final dividend of ₹70 per equity share (7,000%) for FY26, subject to shareholder approval at the upcoming AGM. Including the interim dividend of ₹5 per share already paid during the year, the total dividend payout stands at ₹75 per share. According to NDTV Profit, of the 27 analysts that track this stock, seven have a 'buy' call, 11 have a 'hold' call, and nine have a 'sell' call on the stock. The weak performance was attributed to weak export demand and softness in the domestic market, with analysts noting that the company has been struggling with operating leverage issues that have impacted profitability.
Technical charts indicate continued weakness, with the stock trading below all 8 out of 8 key simple moving averages (SMAs), suggesting a bearish undertone in the near term. The company's agrochemical exports declined 19% year-on-year, while volumes dropped 14% due to a high base effect. Domestic revenue decreased 7% from the previous year, with volumes down 1% owing to adverse weather conditions, weaker crop prices, regulatory disruptions in the biologicals segment, and higher channel inventory levels.
